Literature DB >> 10203544

Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection.

R L Ashley1, M Eagleton, N Pfeiffer.   

Abstract

Sera (n = 188) from 29 patients with first-episode genital herpes simplex virus type 2 (HSV-2) infections were tested by POCkit-HSV-2 and Western blot (WB) to determine the speed of seroconversion. The median time to detection of HSV-2 antibody was 13 days (range, 3 to 102 days) by the POCkit-HSV-2 test versus 13 days (range, 2 to 58 days) for WB.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10203544      PMCID： PMC84860     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections.

Authors:  A Wald; L Koutsky; R L Ashley; L Corey
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

2.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

3.  Evaluation of a novel point of care test for antibodies to herpes simplex virus type 2.

Authors:  R L Ashley; M Eagleton
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

4.  Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.

Authors:  F K Lee; R M Coleman; L Pereira; P D Bailey; M Tatsuno; A J Nahmias
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

5.  The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes.

Authors:  L A Koutsky; R L Ashley; K K Holmes; C E Stevens; C W Critchlow; N Kiviat; C M Lipinski; P Wølner-Hanssen; L Corey
Journal:  Sex Transm Dis       Date:  1990 Apr-Jun       Impact factor: 2.830

6.  Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection.

Authors:  A Langenberg; J Benedetti; J Jenkins; R Ashley; C Winter; L Corey
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

7.  Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens.

Authors:  B Svennerholm; S Olofsson; S Jeansson; A Vahlne; E Lycke
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

8.  Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2.

Authors:  R Ashley; A Cent; V Maggs; A Nahmias; L Corey
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

9.  Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay.

Authors:  M J Slomka; R L Ashley; F M Cowan; A Cross; D W Brown
Journal:  J Virol Methods       Date:  1995-09       Impact factor: 2.014

10.  Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2).

Authors:  D W Ho; P R Field; E Sjögren-Jansson; S Jeansson; A L Cunningham
Journal:  J Virol Methods       Date:  1992-03       Impact factor: 2.014
View more
  22 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

4.  Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.

Authors:  Mina Kalantari-Dehaghi; Sookhee Chun; Aziz Alami Chentoufi; Jozelyn Pablo; Li Liang; Gargi Dasgupta; Douglas M Molina; Algis Jasinskas; Rie Nakajima-Sasaki; Jiin Felgner; Gary Hermanson; Lbachir BenMohamed; Philip L Felgner; D Huw Davies
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  Performance of HSV-2 type specific serological tests in men in Kenya.

Authors:  Musa Otieno Ng'ayo; David Friedrich; King K Holmes; Elizabeth Bukusi; Rhoda Ashley Morrow
Journal:  J Virol Methods       Date:  2009-10-23       Impact factor: 2.014

6.  Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG.

Authors:  Fernando de Ory; María-Eulalia Guisasola; Pilar Balfagón; Juan Carlos Sanz
Journal:  J Clin Lab Anal       Date:  2017-03-23       Impact factor: 2.352

7.  Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.

Authors:  Bodo Rolf Eing; Lars Lippelt; Eva Ulla Lorentzen; Wali Hafezi; Wolfgang Schlumberger; Katja Steinhagen; Joachim Ewald Kühn
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

8. 

Authors:  A Amor; M Sánchez-Conde
Journal:  Medicine (Madr)       Date:  2009-01-06

9.  Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.

Authors:  Ann J Melvin; Kathleen M Mohan; Joshua T Schiffer; Linda M Drolette; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Pediatr       Date:  2014-12-06       Impact factor: 4.406

Review 10.  Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention.

Authors:  Elena Anzivino; Daniela Fioriti; Monica Mischitelli; Anna Bellizzi; Valentina Barucca; Fernanda Chiarini; Valeria Pietropaolo
Journal:  Virol J       Date:  2009-04-06       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.